UPC APP 34218/2025

—

Verfahrensdetails: Status
—
Verfahrensart
Verfahrensantrag
Kategorie
Sonstige prozessuale
Parteien: Kläger
Genevant Sciences GmbH
Arbutus Biopharma Corporation
Vertreter: Markus van Gardingen
Beklagte
Moderna, Inc.
Moderna Belgium S.R.L.
Moderna Denmark ApS
Moderna Sweden AB
Moderna Switzerland GmbH
Moderna Portugal Unipessoal LDA
ModernaTX, Inc.
Moderna Norway AS
Moderna Poland SP. Z.O.O.
Vertreter: Ruben Laddé
Division: The Hague LD
Richter: —
Sprache: —
Erste Entscheidung: 13. Aug. 2025

Entscheidungen

2025-08-13
Generic application
The Hague Local Division considered Genevant/Arbutus's applications to extend deadlines for filing their reply to the defence and statement of defence in counterclaim, following delayed access to confidential information in the Moderna mRNA patent infringement proceedings.
Rechtsfragen:Extension of time limits (Rule 9.3 RoP)Reply deadline after confidentiality orderCounterclaim for revocation procedure

Dokumente